Diseases & Illness | Cancer

Lung Cancer News

New Lung Cancer Drug Given Orphan Drug Status

RSS News Feeds
Disease from Products
Toxic Housing Products
Lung Cancer
 All RSS Feeds

At a glance:

A new drug being studied for cancer treatment has been given "orphan drug" status in order to promote its development.  
 
The drug, picoplatin, is intended for the treatment of small cell lung cancer, in patients who have formed a resistance to platinum. 
 
Platinum therapy for cancer works by disrupting the tumor's DNA, but may be toxic and prone to development of resistance.  
 
Picoplatin is now in clinical trials in the US and Canada.

Picoplatin given orphan-drug status

Platinum today - 7/5/2006 11:19 AM

Orphan-drug designation has just been granted for the platinum compound drug picoplatin.
 
The drug produced by Poniard Pharmaceuticals, formally NeoRx, has received orphan-drug status for the treatment of small cell lung cancer (SCLC), according to CancerConsultants.com
 
· Read The Full Lung Cancer Article From Platinum today -->

· Read All Lung Cancer News Stories -->

Comments On Lung Cancer News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: